Tumor cell adhesion to and migration through the extracellular matrix (ECM) can influence their capacity to disseminate. Since prior studies with Lewis lung carcinoma (LLC) tumors had shown metastatic clones to have more protein kinase A (PKA) activity than nonmetastatic clones, the present study assessed if PKA regulates the interaction between tumor and the ECM, and how this may be associated with the metastatic capacity of the tumor cells. This was accomplished with the use of metastatic (LLC-LN7) and nonmetastatic (LLC-C8) variants that had been stably transfected to overexpress the PKA Ca subunit or to have blocked PKA activity. Cells with increased PKA activity were less adherent to vitronectin, laminin, and collagen I, and could more readily migrate through these ECM components than could transfectants with reduced PKA activity. PKA did not regulate adhesion to or migration through fibronectin, and did not appear to be associated with changes in expression of surface integrins. In addition to modulating tumor adhesion and migration in vitro, PKA activation caused an increased formation of metastases from s.c. tumors, but did not regulate formation of experimental metastases by i.v. injected tumor cells. These results suggest that PKA signaling is important for modulating the tumor-ECM interaction and can facilitate tumor transit from the primary tumor site.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bernstein LR and Liotta LA, 1994, Molecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis. Curr Opin Oncol, 6, 106–13.
Aslakson CJ and Miller FR, 1992,Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res, 52, 1399–405.
Mohler JL, Levy F and Sharief Y, 1991, Metastatic potential and substrate dependence of cell motility and attachment in the Dunning R-3327 rat prostatic adenocarcinoma model. Cancer Res, 50, 6580–5.
Lester BR and McCarthy JB, 1992, Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis. Cancer Metastasis Rev, 11, 31–44.
Smolle J and Grimstad IA, 1992, Tumor-cell motility and invasion within tumors determined by applying computer simulation to histologic patterns. Int J Cancer, 50, 331–5.
Partin AW, Schoeniger JS, Mohler JL and Coffey DS, 1991,Fourier analysis of cell motility: correlation of motility with metastatic potential. Proc Natl Acad Sci USA, 86, 1254–58.
Young MRI, Montpetit M, Lozano Y, et al. 1995, Lewis lung carcinoma transfectants that either overexpress or have defective protein kinase A activity have a respective high or low capacity to invade and metastasize in vivo. Int J Cancer, 64, 104–9.
Juliano RL, 1993, The role of beta 1 integrins in tumors. [Review] Sem Cancer Biol, 4, 277–83.
Gorski A, 1994,The role of cell adhesion molecules in immunopathology. Immunol Today, 15, 251–5.
Trikha M, De Clerk YA and Markland FS, 1994, Contortrostatin, a snake venom disintegrin, inhibits β1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis. Cancer Res, 54, 4993–8.
Elliott BE, Ekblom P, Pross H, Niemann A and Rubin K, 1994, Anti-beta 1 integrin IgG inhibits pulmonary macrometastasis and the size of micrometastases from a murine mammary carcinoma. Cell Adhesions Commun, 1, 319–32.
Tang DG, Grossi IM, Tang KQ, Diglio CA and Horn KV, 1995, Inhibition of TPA and 12(S)-HETEstimulated tumor cell adhesion by prostacyclin and its stable analogs: rationale for their antimetastatic effects. Int J Cancer, 60, 418–25.
Reith A, Bjerkvig R and Rucklidge GJ, 1994,Laminin: a potential inhibitor of rat glioma cell invasion in vitro. Anticancer Res, 14, 1071–6.
Holting T, Zielke A, Siperstein AE, Clark OH and Duh QY, 1994, Transforming growth factor-bl is a negative regulator for differentiated thyroid cancer: studies of growth, migration, invasion, and adhesion of cultured follicular and papillary thyroid cancer cell lines. J Clin Endocr Metab, 79, 806–13.
Young MRI, Lozano Y, Djordjevic A and Maier D, 1993, Protein phosphatases limit tumor motility. Int J Cancer, 54, 1036–41.
Dumont JA and Bitonti AJ, 1994, Modulation of human melanoma cell metastasis and adhesion may involve integrin phosphorylation mediated through protein kinase C. Biochem Biophys, 204, 264–72.
Timar J, Tang D, Bazaz R, et al. 1993, PKC mediates 12(S)-HETE-induced cytoskeletal rearrangement in B 16a melanoma cells. Cell Motil Cytoskel, 26, 49–65.
Young MRI, Duffie GP, Lozano Y, Young ME and Wright MA, 1990, Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants. Cancer Res, 50, 2973–8.
Young MRI, Okada F, Tada M, Hosokawa M and Kobayashi H, 1991, Association of increased tumor cell responsiveness to prostaglandin E2 with more aggressive tumor behavior. Invasion Metastasis 11, 48–57.
Young MRI, Young ME, Lozano Y and Bagash JM, 1992, Activation of protein kinase A increases the in vitro invasion, migration, and adherence to reconstituted basement membrane by Lewis lung carcinoma tumor cells. Invasion Metastasis 12, 253–63.
Young MRI, Young ME, Lozano Y, Coogan M and Bagash JM, 1991, Regulation of protein kinase A activation and prostaglandin E2-stimulated migration of Lewis lung carcinoma clones. Int J Cancer, 49, 150–5.
Young MRI, Charboneau S, Lozano Y, Djordjevic A and Young ME, 1994, Activation of the protein kinase A signal transduction pathway by granulocyte-macrophage colony-stimulating factor or by genetic manipulation reduces cytoskeletal organization in Lewis lung carcinoma variants. Int J Cancer, 54, 446–51
McKnight GS, Uhler MD, Clegg CH, Correll LA and Cadd GG, 1988, Application of molecular genetic techniques to the cAMP- dependent protein kinase system. Method Enzymol, 159, 299–311.
Silletti S, Timar J, Honn KV and Raz A, 1994, Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high- and low-metastatic K 1735 melanoma cell variants. Cancer Res, 54, 5752–6.
Mohler JL, Broskie EN, Ranparia DJ, Sharief Y, Coleman WB and Smith GJ, 1992, Cancer cell motility-inhibitory protein in the Dunning adenocarcinoma model. Cancer Res, 52, 2349–52.
Rosen EM, Knesel J, Goldberg ID, et al. 1994, Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int J Cancer, 57, 706–14.
Onoda JM, Kantak SS, Piechocki MP, et al. 1994, Inhibition of radiation-enhanced expression of integrin and metastatic potential in B16 melanoma cells by a lipoxygenase inhibitor. Radiat Res, 140, 410–18.
Cooper CR, Donald C, Emmett N, Harris-Hooker S and Cooke DB, III, 1993, Adhesion and invasion potential of rat prostatic cancer cells: correlation with metastatic potential. Invasion Metastasis, 13, 178–84.
Busssemakers MJ, van Moorselaar RJ, Giroldi LA, et al. 1992, Decreased expression of E-cadherin in the progression of rat prostatic cancer. Cancer Res, 15, 2916–22.
Rosen EM, Goldberg ID, Liu D, et al. 1991, Tumor necrosis factor stimulates epithelial tumor cell motility. Cancer Res, 51, 5315–21.
Ziegler A, Knesel J, Fabbro D and Nagamine Y, 1991, Protein kinase C down-regulation enhances cAMPmediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells. J Biol Chem, 266, 21067–74.
Cheresh DA, 1992,Structural and biologic properties of integrin-mediated cell adhesion. Clin Lab Med, 12, 217–37.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maier, G.D., Vellody, K., Meisinger, J. et al. Protein kinase A regulates Lewis lung carcinoma adherence to extracellular matrix components and spontaneous metastasis. Clin Exp Metast 14, 314–322 (1996). https://doi.org/10.1007/BF00053905
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00053905